Day Gain | ||
Gain | ||
Market Val | ||
Costs | ||
Cash | ||
Portfolio | ||
Realized | ||
Dividend |
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-05-09 | 2024-03 | -0.21 | N/A | N/A | N/A |
2024-03-14 | 2023-12 | 0 | -0.5 | N/A | N/A |
2023-11-09 | 2023-09 | -0.29 | -0.2 | 0.09 | 31.03% |
2023-11-09 | 2023-09 | -0.29 | N/A | N/A | N/A |
2023-08-10 | 2023-06 | -0.24 | -0.31 | -0.07 | -29.17% |
2023-08-10 | 2023-06 | -0.24 | N/A | N/A | N/A |
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-08-13 | HC Wainwright & Co. | Upgrade | Neutral | Neutral |
2023-05-14 | HC Wainwright & Co. | Upgrade | Neutral | Neutral |
2023-03-19 | HC Wainwright & Co. | Downgrade | Buy | Neutral |
2023-02-22 | HC Wainwright & Co. | Upgrade | Buy | |
2022-11-13 | HC Wainwright & Co. | Upgrade | Buy | |
2022-08-14 | HC Wainwright & Co. | Upgrade | Buy |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2021-05-23 | BENSON REED L | General Counsel | 3.17K | Conversion of Exercise of derivative security |
2023-11-21 | BROWN BRIAN LEE | Chief Financial Officer | 213.22K | Stock Award(Grant) |
2023-11-21 | DURENARD EUGENE A | Director | 85.00K | Stock Award(Grant) |
2023-11-21 | EGAN DWIGHT H | Chief Executive Officer | 270.88K | Stock Award(Grant) |
2023-11-21 | MURPHY TED | Director | 97.50K | Stock Award(Grant) |
2023-11-21 | NELSON JAMES B | Director | 85.00K | Stock Award(Grant) |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Group Inc | 1.78M | 1.98M | 5.79% |
2023-06-29 | Renaissance Technologies, LLC | 653.70K | 725.61K | 2.12% |
2023-06-29 | Blackrock Inc. | 506.51K | 562.22K | 1.65% |
2023-06-29 | Geode Capital Management, LLC | 302.16K | 335.39K | 0.98% |
2023-06-29 | Bridgeway Capital Management, Inc. | 272.90K | 302.92K | 0.89% |
2023-06-29 | Bank Of New York Mellon Corporation | 145.62K | 161.64K | 0.47% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Total Stock Market Index Fund | 1.28M | 1.42M | 4.15% |
2023-06-29 | Vanguard Extended Market Index Fund | 444.78K | 493.70K | 1.44% |
2023-06-29 | Bridgeway Funds Inc-Ultra Small Company Fund | 272.90K | 302.92K | 0.89% |
2023-05-30 | Fidelity Extended Market Index Fund | 165.22K | 180.09K | 0.54% |
2023-08-30 | iShares Micro Cap ETF | 69.84K | 86.60K | 0.23% |
2023-05-30 | Fidelity Total Market Index Fund | 53.59K | 58.41K | 0.17% |
-
$CODX -has to stabilize above 14
-
$CODX - undervalued company
-
$CODX - My chart , enjoy
https://twitter.com/shmulic12/status/1310655955713941504?s=21
-
$CODX - very strong momentum, although we see some red sometimes. Whoever is long here can stay calm as long stock price remains above 13.
-
$CODX - Bullish flag pattern 1h chart , target above 16. Good luck
-
$CODX - I WARN THE BEARS! Published a 1h chart! There is a nice uptrend line ! Good for the bulls
-
$CODX - Shorts are working hard for nothing. Keep in mind that more COVID cases, better incomes and growth.
-
$CODX - when the market drops, covid stocks probably will go up.
-
$CODX - there will be more demands to the company. Revenue is going to be increased
-
-
$CODX - The demands are going to be increased. Direct impact to incoming revenue.
-
$CODX - Hopefully 15 today, and a nice squeeze above it
-
$CODX - weak hands sells first , strong hands are buying first
-
$CODX - For those who always writing on here Co primers . Go back to your caves and have a good sleep. The winter is coming for you all.
-
-
$CODX - Whom ever will check the inventory reported in the last financial report, will meet the number 10 million dollars, a viewpoint on incoming revenue.
-
$CODX - Tested the support 14$. Very healthy for long
-
$CODX - above 14$ , the gate is open, bears using the SL NOW
-
Co-Diagnostics, Inc. (CODX) Q4 2023 Earnings Call Transcript
seekingalpha.com • -
Co-Diagnostics, Inc. (CODX) Q3 2023 Earnings Call Transcript
seekingalpha.com • -
Co-Diagnostics, Inc. (CODX) Q1 2023 Earnings Call Transcript
seekingalpha.com • -
Co-Diagnostics, Inc. (CODX) Q4 2022 Earnings Call Transcript
seekingalpha.com • -
Co-Diagnostics, Inc. (CODX) Q3 2022 Earnings Call Transcript
seekingalpha.com • -
7 Vaccine Stocks to Sell ASAP Now That the ‘Pandemic's Over'
investorplace.com • -
Why Co-Diagnostics Stock Slipped Today
fool.com • -
Co-Diagnostics set to expand OEM deal with Bio Molecular Systems at AACC expo
proactiveinvestors.com • -
CODX Stock Pops as Co-Diagnostics Ships Out Monkeypox Tests
investorplace.com • -
Why Co-Diagnostics Stock Is Rising Today
fool.com • -
Why Co-Diagnostics Is Running Higher Today
fool.com • -
Co-Diagnostics develops principal design work on monkeypox PCR test
proactiveinvestors.com • -
Why Co-Diagnostics Stock Is Trading Higher After Hours
benzinga.com • -
Co-Diagnostics adds four new experts to its Scientific Advisory Board
proactiveinvestors.com • -
Why Co-Diagnostics Is Soaring Today
fool.com • -
Why Co-Diagnostics Shares Are Trading Higher Today
benzinga.com • -
Co-Diagnostics: Swinging For The Fences
seekingalpha.com • -
4 Stocks With High Growth Potential
gurufocus.com • -
7 Stocks to Buy to Hedge Against Omicron Variant Risks
investorplace.com • -
Co-Diagnostics partners with TiiCKER to increase connection with retail investors
proactiveinvestors.com • -
Co-Diagnostics sees record 3Q revenue of $30.1M on Logix Smart coronavirus test sales
proactiveinvestors.com • -
Co-Diagnostics says its Logix Smart COVID-19 test has been approved for sale in the UK
proactiveinvestors.com • -
Co-Diagnostics fighting coronavirus (COVID-19) with flagship test, plans at-home PCR-based platform
proactiveinvestors.com • -
Co-Diagnostics announces corporate rebranding after period of transformative growth and expansion
proactiveinvestors.com • -
Co-Diagnostics says its Logix Smart ABC Test is authorized for use in Mexico
proactiveinvestors.com • -
Why Co-Diagnostics Is A Solid Covid-19 Play
seekingalpha.com • -
Co-Diagnostics sees 2Q revenue rise by 13.8% driven by sales of the Logix Smart COVID-19 Test
proactiveinvestors.com • -
Why Co-Diagnostics Shares Are Skyrocketing Today
benzinga.com •